While there is plenty of speculation out there about possible suitors for 570-rep IBD Investors Capital, industry consultants note that so far the process hasn't moved like a normal broker merger.
Chip Roame of Tiburon tells Research that simply filing to sell a controlling stake is not usually how a publicly traded company puts itself on the acquisitions block.
And since he hasn't heard about any high-level discussions with investment bankers, that kind of transaction doesn't seem to be on the table.
Instead, Investors Capital's founder may simply be looking to retire and distribute his shares among existing shareholders and management. This would likely be a positive for the firm's reps, who would get to remain independent of any of the competitors that have been touted as possible buyers.